Samphire Neuroscience raised a $2.3M pre-seed round for its neurotech wearable which uses low transcranial currents to reduce sensitivity and block pain for a number of women’s health conditions. Seaside Ventures, FIRSTPICK, CVX, and AfterWork invested.
- Company
- Samphire Neuroscience samphireneuro.com
- Round
- Pre-Seed
- Amount
- $2.3M
- Source
- techcrunch.com
- In the newsletter
- No. 75, Factory Gameplay & Semiconductor Startups